US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist
  • 2.370
  • 0.0000.00%
Close Nov 29 13:00 ET
  • 2.370
  • 0.0000.00%
Post 15:16 ET
95.54MMarket Cap21.55P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-50.43%1.34M
0
0
0.00%674K
0.00%666K
199.00%2.7M
-0.29%681K
Operating revenue
--0
--0
--0
-50.43%1.34M
--0
--0
0.00%674K
0.00%666K
199.00%2.7M
-0.29%681K
Cost of revenue
Gross profit
Operating expense
6.77%3.09M
-29.79%3.14M
-49.57%2.96M
-60.49%17.11M
-62.80%3.88M
-67.39%2.89M
-63.07%4.47M
-50.71%5.87M
227.29%43.3M
28.77%10.42M
Selling and administrative expenses
-56.25%847K
-35.97%1.69M
23.22%1.78M
-48.04%8.14M
-32.86%2.11M
-45.06%1.94M
-9.20%2.64M
-76.21%1.45M
273.53%15.66M
39.80%3.14M
-Selling and marketing expense
--0
--0
--0
-115.51%-287K
--0
-243.20%-663K
-49.47%192K
-68.81%184K
106.12%1.85M
--418K
-General and administrative expense
-67.41%847K
-30.95%1.69M
41.17%1.78M
-39.00%8.43M
-22.56%2.11M
-15.09%2.6M
-3.16%2.45M
-77.00%1.26M
319.15%13.81M
21.21%2.73M
Research and development costs
134.27%2.24M
-20.81%1.44M
-73.37%1.18M
-67.54%8.97M
-75.73%1.77M
-82.10%957K
-80.16%1.82M
-24.14%4.43M
205.84%27.64M
24.52%7.28M
Operating profit
-6.77%-3.09M
17.30%-3.14M
43.13%-2.96M
61.16%-15.77M
60.20%-3.88M
64.67%-2.89M
66.80%-3.79M
53.71%-5.21M
-229.37%-40.6M
-31.44%-9.74M
Net non-operating interest income expense
-3,843.73%-15.42M
463.88%13.97M
181.53%4.5M
28.76%4.59M
-44.61%905K
-137.74%-391K
608.00%2.48M
193.57%1.6M
2,214.29%3.56M
344.25%1.63M
Non-operating interest income
----
474.41%14.23M
218.60%5.09M
124.63%8.03M
114.00%3.52M
-58.01%435K
608.00%2.48M
193.57%1.6M
2,175.80%3.57M
--1.64M
Non-operating interest expense
1,766.83%15.42M
--261K
--592K
--2.04M
--1.21M
--826K
--0
--0
--0
--0
Total other finance cost
----
----
----
15,455.56%1.4M
----
----
----
----
800.00%9K
----
Other net income (expense)
2,682.22%16.27M
-659.04%-630K
Gain on sale of security
----
----
----
2,682.22%16.27M
----
----
----
----
-659.04%-630K
----
Income before tax
-463.61%-18.51M
925.44%10.84M
142.48%1.53M
113.51%5.09M
252.20%13.3M
54.09%-3.28M
88.14%-1.31M
66.28%-3.61M
-207.34%-37.66M
-21.57%-8.74M
Income tax
1.13M
1.63M
0
0
0
0
100K
0
Net income
-498.11%-19.64M
800.99%9.2M
142.48%1.53M
113.47%5.09M
252.20%13.3M
54.72%-3.28M
88.14%-1.31M
66.28%-3.61M
-208.15%-37.76M
-21.57%-8.74M
Net income continuous Operations
-498.11%-19.64M
800.99%9.2M
142.48%1.53M
113.47%5.09M
252.20%13.3M
54.72%-3.28M
88.14%-1.31M
66.28%-3.61M
-208.15%-37.76M
-21.57%-8.74M
Minority interest income
62.90%-23K
93.28%-8K
99.07%-2K
63.67%-437K
79.27%-40K
67.88%-62K
77.72%-119K
23.67%-216K
-104.94%-1.2M
42.04%-193K
Net income attributable to the parent company
-508.91%-19.62M
871.52%9.21M
145.24%1.54M
115.11%5.53M
256.10%13.34M
54.36%-3.22M
88.66%-1.19M
67.43%-3.4M
-213.34%-36.56M
-24.66%-8.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-508.91%-19.62M
871.52%9.21M
145.24%1.54M
115.11%5.53M
256.10%13.34M
54.36%-3.22M
88.66%-1.19M
67.43%-3.4M
-213.34%-36.56M
-24.66%-8.54M
Basic earnings per share
-500.00%-0.48
833.33%0.22
150.00%0.04
114.89%0.14
250.00%0.33
55.56%-0.08
88.89%-0.03
70.37%-0.08
-203.23%-0.94
-4.76%-0.22
Diluted earnings per share
-500.00%-0.48
833.33%0.22
150.00%0.04
114.89%0.14
250.00%0.33
55.56%-0.08
88.89%-0.03
70.37%-0.08
-203.23%-0.94
-4.76%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-50.43%1.34M000.00%674K0.00%666K199.00%2.7M-0.29%681K
Operating revenue --0--0--0-50.43%1.34M--0--00.00%674K0.00%666K199.00%2.7M-0.29%681K
Cost of revenue
Gross profit
Operating expense 6.77%3.09M-29.79%3.14M-49.57%2.96M-60.49%17.11M-62.80%3.88M-67.39%2.89M-63.07%4.47M-50.71%5.87M227.29%43.3M28.77%10.42M
Selling and administrative expenses -56.25%847K-35.97%1.69M23.22%1.78M-48.04%8.14M-32.86%2.11M-45.06%1.94M-9.20%2.64M-76.21%1.45M273.53%15.66M39.80%3.14M
-Selling and marketing expense --0--0--0-115.51%-287K--0-243.20%-663K-49.47%192K-68.81%184K106.12%1.85M--418K
-General and administrative expense -67.41%847K-30.95%1.69M41.17%1.78M-39.00%8.43M-22.56%2.11M-15.09%2.6M-3.16%2.45M-77.00%1.26M319.15%13.81M21.21%2.73M
Research and development costs 134.27%2.24M-20.81%1.44M-73.37%1.18M-67.54%8.97M-75.73%1.77M-82.10%957K-80.16%1.82M-24.14%4.43M205.84%27.64M24.52%7.28M
Operating profit -6.77%-3.09M17.30%-3.14M43.13%-2.96M61.16%-15.77M60.20%-3.88M64.67%-2.89M66.80%-3.79M53.71%-5.21M-229.37%-40.6M-31.44%-9.74M
Net non-operating interest income expense -3,843.73%-15.42M463.88%13.97M181.53%4.5M28.76%4.59M-44.61%905K-137.74%-391K608.00%2.48M193.57%1.6M2,214.29%3.56M344.25%1.63M
Non-operating interest income ----474.41%14.23M218.60%5.09M124.63%8.03M114.00%3.52M-58.01%435K608.00%2.48M193.57%1.6M2,175.80%3.57M--1.64M
Non-operating interest expense 1,766.83%15.42M--261K--592K--2.04M--1.21M--826K--0--0--0--0
Total other finance cost ------------15,455.56%1.4M----------------800.00%9K----
Other net income (expense) 2,682.22%16.27M-659.04%-630K
Gain on sale of security ------------2,682.22%16.27M-----------------659.04%-630K----
Income before tax -463.61%-18.51M925.44%10.84M142.48%1.53M113.51%5.09M252.20%13.3M54.09%-3.28M88.14%-1.31M66.28%-3.61M-207.34%-37.66M-21.57%-8.74M
Income tax 1.13M1.63M0000100K0
Net income -498.11%-19.64M800.99%9.2M142.48%1.53M113.47%5.09M252.20%13.3M54.72%-3.28M88.14%-1.31M66.28%-3.61M-208.15%-37.76M-21.57%-8.74M
Net income continuous Operations -498.11%-19.64M800.99%9.2M142.48%1.53M113.47%5.09M252.20%13.3M54.72%-3.28M88.14%-1.31M66.28%-3.61M-208.15%-37.76M-21.57%-8.74M
Minority interest income 62.90%-23K93.28%-8K99.07%-2K63.67%-437K79.27%-40K67.88%-62K77.72%-119K23.67%-216K-104.94%-1.2M42.04%-193K
Net income attributable to the parent company -508.91%-19.62M871.52%9.21M145.24%1.54M115.11%5.53M256.10%13.34M54.36%-3.22M88.66%-1.19M67.43%-3.4M-213.34%-36.56M-24.66%-8.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -508.91%-19.62M871.52%9.21M145.24%1.54M115.11%5.53M256.10%13.34M54.36%-3.22M88.66%-1.19M67.43%-3.4M-213.34%-36.56M-24.66%-8.54M
Basic earnings per share -500.00%-0.48833.33%0.22150.00%0.04114.89%0.14250.00%0.3355.56%-0.0888.89%-0.0370.37%-0.08-203.23%-0.94-4.76%-0.22
Diluted earnings per share -500.00%-0.48833.33%0.22150.00%0.04114.89%0.14250.00%0.3355.56%-0.0888.89%-0.0370.37%-0.08-203.23%-0.94-4.76%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data